MUKILTEO, Wash., Oct. 8, 2008 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) held a web-broadcast on October 7, 2008 to discuss its development of a Comprehensive Cancer Array (CCA) test for the non-invasive screening of multiple cancers simultaneously. The CCA is a test that is in CombiMatrix's development pipeline and is planned for launch in 18-24 months.
